Study details
Enrolling now
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
Yale University
NCT IDNCT05317455ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
16
Study length
about 1.1 years
Ages
18–55
Locations
1 site in CT
What this study is about
Researchers are testing if dichloroacetate can help restore brain glucose metabolism in people with type 1 diabetes who experience hypoglycemia unawareness. The trial will last for about 413 days and involves a total of approximately 16 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Dichloroacetate
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Cognitive Function
Body systems
Endocrinology